drugset
drugset / Trial / NCT03851341

Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers

NCT03851341 ↗

Phase 1 Completed 30 enrolled GL Pharm Tech Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

Crossover study to compare the pharmacokinetic characteristics of GLH1SM sustained release tablet and Janumet XR tablet in fasting condition

Timeline

Start
2019-01-02
Primary completion
2019-01-12
Completion
2019-01-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg —
Subject Sitagliptin Small molecule 100 mg —

Indications

No indication recorded.